S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 129.4 SEK 0.7%
Market Cap: 6.6B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Surgical Science Sweden AB
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Surgical Science Sweden AB
Income from Continuing Operations Peer Comparison

Comparables:
EKTA B
CEVI
GETI B
ARJO B
S
STIL

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgical Science Sweden AB
STO:SUS
Income from Continuing Operations
kr197.7m
CAGR 3-Years
110%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Income from Continuing Operations
kr1.3B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Income from Continuing Operations
kr145.1m
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
15%
Getinge AB
STO:GETI B
Income from Continuing Operations
kr2.4B
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Income from Continuing Operations
kr480m
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Income from Continuing Operations
kr47.9m
CAGR 3-Years
56%
CAGR 5-Years
20%
CAGR 10-Years
33%

See Also

What is Surgical Science Sweden AB's Income from Continuing Operations?
Income from Continuing Operations
197.7m SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Income from Continuing Operations amounts to 197.7m SEK.

What is Surgical Science Sweden AB's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
110%

Over the last year, the Income from Continuing Operations growth was -15%. The average annual Income from Continuing Operations growth rates for Surgical Science Sweden AB have been 110% over the past three years .

Back to Top